Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy

Omar Wever-Pinzon1, Jorge Romero, Juan P Cordova

  • 1Division of Cardiology, University of Utah, Salt Lake City, UT.

Insights

Japanese-variant hypertrophic cardiomyopathy (HCM) can cause severe symptoms. Dual chamber pacing effectively relieved obstruction and improved symptoms in a patient unresponsive to medical therapy.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Japanese-variant hypertrophic cardiomyopathy (HCM), or apical HCM, was initially considered benign.
  • Recent evidence indicates severe symptoms and increased risk of arrhythmias and death in these patients, particularly with an apical akinetic chamber.
  • Management of medically refractory HCM patients presents significant challenges.

Purpose of the Study:

  • To present a case of Japanese-variant HCM with an apical akinetic chamber and severe symptoms refractory to medical treatment.
  • To evaluate the efficacy of dual chamber pacing in managing such a complex case.

Main Methods:

  • Case report of a patient with Japanese-variant HCM, apical akinetic chamber, and severe symptoms.
  • Patient failed to respond to conventional medical therapy.
  • Intervention involved the use of dual chamber pacing.

Main Results:

  • Dual chamber pacing successfully relieved left ventricular outflow tract obstruction.
  • Significant improvement in the patient's severe symptoms was observed post-pacing.
  • The intervention demonstrated a positive impact on symptom management in a challenging HCM subtype.

Conclusions:

  • Dual chamber pacing is a viable therapeutic option for patients with Japanese-variant HCM and an apical akinetic chamber who are refractory to medical therapy.
  • This approach can effectively alleviate obstruction and improve clinical outcomes.
  • Further research may explore the broader application of pacing in managing obstructive HCM variants.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...